BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 15170927)

  • 1. Influence of Serum Amyloid A (SAA1) and SAA2 gene polymorphisms on renal amyloidosis, and on SAA/C-reactive protein values in patients with familial mediterranean fever in the Turkish population.
    Bakkaloglu A; Duzova A; Ozen S; Balci B; Besbas N; Topaloglu R; Ozaltin F; Yilmaz E
    J Rheumatol; 2004 Jun; 31(6):1139-42. PubMed ID: 15170927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the modifying effects of SAA1, SAA2 and TNF-alpha gene polymorphisms on development of amyloidosis in FMF patients.
    Yilmaz E; Balci B; Kutlay S; Ozen S; Ertürk S; Oner A; Beşbaş N; Bakkaloğlu A
    Turk J Pediatr; 2003; 45(3):198-202. PubMed ID: 14696796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum amyloid A serum concentrations and genotype do not explain low incidence of amyloidosis in Hyper-IgD syndrome.
    van der Hilst JC; Drenth JP; Bodar EJ; Bijzet J; van der Meer JW; Simon A;
    Amyloid; 2005 Jun; 12(2):115-9. PubMed ID: 16011988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic risk factors of amyloidogenesis in familial Mediterranean fever.
    Delibaş A; Oner A; Balci B; Demircin G; Bulbul M; Bek K; Erdoğan O; Baysun S; Yilmaz E
    Am J Nephrol; 2005; 25(5):434-40. PubMed ID: 16118480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single testing of serum amyloid a levels as a tool for diagnosis and treatment dilemmas in familial Mediterranean fever.
    Berkun Y; Padeh S; Reichman B; Zaks N; Rabinovich E; Lidar M; Shainberg B; Livneh A
    Semin Arthritis Rheum; 2007 Dec; 37(3):182-8. PubMed ID: 17512038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Familial Mediterranean Fever (FMF): from diagnosis to treatment].
    Medlej-Hashim M; Loiselet J; Lefranc G; Mégarbané A
    Sante; 2004; 14(4):261-6. PubMed ID: 15745878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The contribution of genotypes at the MEFV and SAA1 loci to amyloidosis and disease severity in patients with familial Mediterranean fever.
    Gershoni-Baruch R; Brik R; Zacks N; Shinawi M; Lidar M; Livneh A
    Arthritis Rheum; 2003 Apr; 48(4):1149-55. PubMed ID: 12687559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MEFV and SAA1 genotype associations with clinical features of familial Mediterranean fever and amyloidosis in Armenia.
    Atoyan S; Hayrapetyan H; Sarkisian T; Ben-Chetrit E
    Clin Exp Rheumatol; 2016; 34(6 Suppl 102):72-76. PubMed ID: 27791951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased susceptibility of serum amyloid A 1.1 to degradation by MMP-1: potential explanation for higher risk of type AA amyloidosis.
    van der Hilst JC; Yamada T; Op den Camp HJ; van der Meer JW; Drenth JP; Simon A
    Rheumatology (Oxford); 2008 Nov; 47(11):1651-4. PubMed ID: 18815155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum amyloid A1 -13 T/C alleles in Turkish familial Mediterranean fever patients with and without amyloidosis.
    Akar N; Hasipek M; Oztürk A; Akar E; Tekin M
    J Nephrol; 2006; 19(3):318-21. PubMed ID: 16874691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of SAA1.3 allele genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritis.
    Nakamura T; Higashi S; Tomoda K; Tsukano M; Baba S; Shono M
    Rheumatology (Oxford); 2006 Jan; 45(1):43-9. PubMed ID: 16219644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloidosis in familial Mediterranean fever patients: correlation with MEFV genotype and SAA1 and MICA polymorphisms effects.
    Medlej-Hashim M; Delague V; Chouery E; Salem N; Rawashdeh M; Lefranc G; Loiselet J; Mégarbané A
    BMC Med Genet; 2004 Feb; 5():4. PubMed ID: 15018633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum amyloid A1 and tumor necrosis factor-alpha alleles in Turkish familial Mediterranean fever patients with and without amyloidosis.
    Akar N; Hasipek M; Akar E; Ekim M; Yalçinkaya F; Cakar N
    Amyloid; 2003 Mar; 10(1):12-6. PubMed ID: 12762136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Amyloidosis of familial Mediterranean fever (FMF)--insights to FMF phenotype II].
    Livneh A
    Harefuah; 2006 Oct; 145(10):743-5, 782. PubMed ID: 17111710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of plasminogen activator inhibitor-1 -675 4G/5G polymorphism on familial Mediterranean fever (FMF) disease.
    Ozel Demiralp D; Ekim M; Akar N
    Clin Appl Thromb Hemost; 2009; 15(4):443-7. PubMed ID: 19033264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anaemia of chronic disease in AA amyloidosis is associated with allele 2 of the interleukin-1beta-511 promoter gene and raised levels of interleukin-1beta and interleukin-18.
    Maury CP; Liljeström M; Laiho K; Tiitinen S; Kaarela K; Hurme M
    J Intern Med; 2004 Aug; 256(2):145-52. PubMed ID: 15257727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The frequencies of the serum amyloid A2 alleles in healthy (Turkish, Azerbaijan and Kazakh) populations.
    Taştan H; Osmanagaoglu O; Tuzun A
    Genetika; 2005 Jul; 41(7):986-9. PubMed ID: 16152805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of serum amyloid A1 alleles by PCR-RFLP].
    Yamada T; Itoh Y; Itoh K
    Rinsho Byori; 1999 Jan; 47(1):53-5. PubMed ID: 10067365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AA amyloidosis-resistant CE/J mice have Saa1 and Saa2 genes that encode an identical SAA isoform.
    Mori M; Tiang G; Higuchi K
    Amyloid; 2014 Mar; 21(1):1-8. PubMed ID: 24228751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting genetic risk factors for AA amyloidosis in Algerian patients with familial Mediterranean fever.
    Ait-Idir D; Djerdjouri B; Latreche K; Sari-Hamidou R; Khellaf G
    Mol Genet Genomics; 2024 Mar; 299(1):25. PubMed ID: 38451362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.